Effect of 5-azacytidine and galectin-1 on growth and differentiation of the human b lymphoma cell line bl36

Effect of 5-azacytidine and galectin-1 on growth and differentiation of the human b lymphoma cell line bl36

<p>Abstract</p> <p>Background</p> <p>5-AzaCytidine (AzaC) is a DNA demethylating drugs that has been shown to inhibit cell growth and to induce apoptosis in certain cancer cells. Induced expression of the galectin1 (Gal1) protein, a galactoside-binding protein distribut...

Full description

Bibliographic Details
Main Authors:	Joubert-Caron Raymonde, Bladier Dominique, Bourin Philippe, Poirier Florence, Caron Michel
Format:	Article
Language:	English
Published:	BMC 2001-12-01
Series:	Cancer Cell International
Online Access:	http://www.biomedcentral.com/1475-2867/1/2

Similar Items

Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma
by: Kamel Laribi, et al.
Published: (2022-02-01)

5-azacytidine for beta-thalassemia?
by: Clegg, J, et al.
Published: (1983)

Azacytidine Treatment for VEXAS Syndrome
by: Marc H. G. P. Raaijmakers, et al.
Published: (2021-12-01)

Modulation of osteogenic differentiation in human skeletal cells in Vitro by 5-azacytidine.
by: Locklin, R, et al.
Published: (1998)

P1224: PATIENT-DERIVED XENOGRAFT (PDX) IS A USEFUL TOOL FOR EVALUATING 5-AZACYTIDINE SENSITIVITY IN TFH LYMPHOMAS
by: Gamze Tari, et al.
Published: (2023-08-01)

Photoperiod sensitivity of Canadian flax cultivars and 5-azacytidine treated early flowering derivative lines
by: Jia Sun, et al.
Published: (2019-05-01)

The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry
by: Panagiotis Diamantopoulos, et al.
Published: (2019-05-01)

Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines.
by: Sabine Hagemann, et al.
Published: (2011-01-01)

Suppressing nonsense—a surprising function for 5‐azacytidine
by: Ada Shao, et al.
Published: (2014-12-01)

Cytogenetic effect of 5-azacytidine in patients with hematological malignancies
by: Jessica Romy Tsuda, et al.
Published: (2011-10-01)

Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease
by: Gilles Fransolet, et al.
Published: (2016-07-01)

Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience
by: Valentina Giudice, et al.
Published: (2022-12-01)

Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?
by: Yuanwei Shi, et al.
Published: (2022-05-01)

Effect of 5- Azacytidine on the Cell Growth Inhibition and Apoptosis Induction Lung Cancer A549 Cell Line
by: M Sanaei Jahromi, et al.
Published: (2020-10-01)

Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports
by: Peter Rohon, et al.
Published: (2012-01-01)

Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy
by: Xu N, et al.
Published: (2021-04-01)

Synthesis and Antiproliferative Activities of 5-Azacytidine Analogues in Human Leukemia Cells
by: Lin-Xiang Zhao, et al.
Published: (2008-07-01)

A Comparative Analysis of 5-Azacytidine- and Zebularine-Induced DNA Demethylation
by: Patrick T. Griffin, et al.
Published: (2016-09-01)

5-azacytidine improves the osteogenic differentiation potential of aged human adipose-derived mesenchymal stem cells by DNA demethylation.
by: Xueying Yan, et al.
Published: (2014-01-01)

Expression and functions of galectin-7 in human and murine melanomas.
by: Katherine Biron-Pain, et al.
Published: (2013-01-01)

5-Azacytidine treatment of the patient with ATMDS (vol 76, pg 432, 2006)
by: Costa, D, et al.
Published: (2006)

Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine
by: Marco Manzoni, et al.
Published: (2022-05-01)

5‐azacytidine inhibits nonsense‐mediated decay in a MYC‐dependent fashion
by: Madhuri Bhuvanagiri, et al.
Published: (2014-12-01)

Resistance of Leukemia Cells to 5-Azacytidine: Different Responses to the Same Induction Protocol
by: Kristína Šimoničová, et al.
Published: (2023-06-01)

Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways
by: Lubomír Minařík, et al.
Published: (2022-01-01)

5-Azacytidine-Mediated Modulation of the Immune Microenvironment in Murine Acute Myeloid Leukemia
by: Nancy D. Ebelt, et al.
Published: (2022-12-01)

Methyl Transferase Inhibitor 5-Azacytidine Suppresses Experimental Abdominal Aortic Aneurysms
by: Toru Ikezoe, et al.
Published: (2022-01-01)

The effects of the DNA Demethylating reagent, 5-azacytidine on SMCHD1 genomic localization
by: S. Massah, et al.
Published: (2020-01-01)

NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes
by: Jonas P. Becker, et al.
Published: (2021-04-01)

Vers une synthèse vocale du français classique à l’aide du logiciel ©KALI
by: Philippe Caron, et al.

Clinical Relevance of Galectin-1 and Galectin-3 in Rheumatoid Arthritis Patients: Differential Regulation and Correlation With Disease Activity
by: Santiago P. Mendez-Huergo, et al.
Published: (2019-01-01)

Prognostic role of galectin-3 expression in patients with solid tumors: a meta-analysis of 36 eligible studies
by: Yi Wang, et al.
Published: (2018-11-01)

Galectins Differentially Regulate the Surface Glycosylation of Human Monocytes
by: Dina B. AbuSamra, et al.
Published: (2022-08-01)

The role of Galectin-3 in the differentiation of neural stem cells
by: Campos Soares, L
Published: (2020)

Galectin-3 contributes to neonatal hypoxic–ischemic brain injury
by: Christina Doverhag, et al.
Published: (2010-04-01)

The combination of bFGF and hydrocortisone is a better alternative compared to 5-azacytidine for cardiomyogenic differentiation of bone marrow and adipose stem cells
by: Nadiah Sulaiman,, et al.
Published: (2021)

Cardiac Differentiation of Adipose Tissue-Derived Stem Cells Is Driven by BMP4 and bFGF but Counteracted by 5-Azacytidine and Valproic Acid
by: Sanaz Hasani, et al.
Published: (2020-10-01)

Cytocidal activities of topoisomerase 1 inhibitors and 5-azacytidine against pheochromocytoma/paraganglioma cells in primary human tumor cultures and mouse cell lines.
by: James F Powers, et al.
Published: (2014-01-01)

ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine
by: Rahmani, NE, et al.
Published: (2021)

PB1998: AZACYTIDINE AND ALLOGENOUS STEM CELL TRANSPLANTATION IN LATE-ONSET ERYTHROPOIETIC PROTOPORPHYRIA
by: Daniel El Fassi, et al.
Published: (2023-08-01)